OMEROS CORP Uncategorized Contracts & Agreements

73 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Credit and Guaranty Agreement, dated as of June 3, 2024, among the Company, certain subsidiaries of the Company, as guarantors, various Lenders and Wilmington Savings Fund...
OMEROS CORP
Pharmaceuticals
NY
2024
Pledge and Security Agreement, dated as of June 3, 2024, between the Company, nura inc. and Wilmington Savings Fund Society, FSB, as Collateral Agent
OMEROS CORP
Pharmaceuticals
2024
Form of Capped Call Transaction Confirmation
OMEROS CORP
Pharmaceuticals
NY
2020
TABLE OF CONTENTS
OMEROS CORP
Pharmaceuticals
NY
2014
30 SunnysideAvenue | Mill Valley | CA 94941 | (415) 383-4700 | Fax ###-###-####
OMEROS CORP
Pharmaceuticals
CA
2011
Life Sciences Discovery Fund LSDF 10-05 Opportunity Grant Grant Award Agreement
OMEROS CORP
Pharmaceuticals
WA
2011
Current assets
OMEROS CORP
Pharmaceuticals
DE
2010
30 Sunnyside Avenue | Mill Valley | CA 94941 | (415) 383-4700 | Fax ###-###-####
OMEROS CORP
Pharmaceuticals
CA
2010
Current assets
OMEROS CORP
Pharmaceuticals
NY
2010
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
OMEROS CORP
Pharmaceuticals
WA
2010
FIRST AMENDMENT
OMEROS CORP
Pharmaceuticals
2010
FIRST AMENDMENT OF EXCLUSIVE TECHNOLOGY OPTION AGREEMENT
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
WA
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
CA
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
DE
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
DE
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
WA
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
WA
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2009
OMEROS CORPORATION
OMEROS CORP
Pharmaceuticals
WA
2009
EXCLUSIVE TECHNOLOGY OPTION AGREEMENT
OMEROS CORP
Pharmaceuticals
WA
2009
DATED 20 April 2007
OMEROS CORP
Pharmaceuticals
DE
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
WA
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
WA
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
WA
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
CA
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
DE
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
WA
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2008